DataMeds AI (MEDS) Payables (2023 - 2026)

DataMeds AI (MEDS) has reported Payables for 4 consecutive years, with $12.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Payables rose 45.87% year-over-year to $12.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.0 million (up 45.87% YoY), and the FY2025 full-year result was $11.7 million, up 84.9% from the prior year.
• Payables climbed to $12.0 million in Q1 2026 per MEDS's latest filing, from $11.7 million in the prior quarter.
• Across five years, Payables topped out at $14.4 million in Q3 2025 and bottomed at $100000.0 in Q3 2024.
• Historically, Payables has averaged $7.9 million across 4 years, with a median of $8.8 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Payables jumped 14330.56% in 2025, then jumped 45.87% in 2026.
• Over 4 years, Payables stood at $1.0 million in 2023, then soared by 507.39% to $6.3 million in 2024, then jumped by 84.9% to $11.7 million in 2025, then gained by 2.68% to $12.0 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $12.0 million, $11.7 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.